SCHEMBL18360577

SCHEMBL18360577

CN(C)C[C@@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5783642 1.00
SCHEMBL21232047 1.00
Hydrochloric Acid SCHEMBL5784452 0.97
Hydrochloric Acid SCHEMBL31603446 0.97
SCHEMBL2916954 0.84
SCHEMBL10059315 0.82
SCHEMBL1401177 0.82
SCHEMBL588857 0.82
Hydrochloric Acid SCHEMBL20520978 0.80 GHSR (0.35)
Hydrochloric Acid SCHEMBL1190877 0.80 GHSR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021076448-A1 SOMATOSTATIN MODULATORS FOR TREATING PITUITARY ADENOMAS Crinetics Pharmaceuticals, Inc. (US) 2021-04-22 WO disclosed
EP-3317277-B1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2021-01-20 EP disclosed
WO-2017003723-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2017-01-05 WO disclosed